secwatch.observer — SEC 8-K summary
======================================

Issuer:     Avinger Inc (—)
CIK:        0001506928
Form:       8-K
Filed at:   2024-03-07T23:59:59+00:00
Accession:  0001437749-24-006895
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.80
Item codes: 1.01, 5.03, 2.03, 3.02, 5.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Avinger enters strategic partnership with Zylox-Tonbridge, raises $7.5M initial tranche with potential $15M total
--------------------------------------------------------------------------------

- License and distribution agreement with Zylox-Tonbridge for Greater China; 20-year term with mid- to high-single-digit royalties.
- Initial $7.5M private placement closed: 75,327 common shares and 7,224 Series F preferred shares at $3.664 per common share.
- Up to additional $7.5M from Zylox-Tonbridge upon achieving two milestones: FDA registration and $10M gross revenue in four consecutive quarters.
- Existing Series A preferred stock exchanged for Series A-1 preferred convertible at same $3.664 price; CRG loan amended extending interest-only period through 2026.
- Jonathon Zhong Zhao appointed to Board; stockholder consent obtained for all transactions.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1506928/000143774924006895/0001437749-24-006895-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1506928/000143774924006895/avgr20240223_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-24-006895

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer